Research ArticleExperimental Studies

Beta-(1-3),(1-6)-D-glucan Enhances the Effect of Low-dose Cyclophosphamide Treatment on A20 Lymphoma in Mice

ULF HARNACK, KLAUS ECKERT and GABRIELE PECHER
Anticancer Research April 2011, 31 (4) 1169-1172;

Article Information

vol. 31 no. 4 1169-1172
PubMed 
21508361
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 15, 2011
  • Revision received March 17, 2011
  • Accepted March 18, 2011
  • Published online April 20, 2011.
Copyright & Usage 
Copyright© 2011 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ULF HARNACK1,
  2. KLAUS ECKERT2 and
  3. GABRIELE PECHER1⇓
  1. 1Medical Clinic of Oncology and Hematology, Charité University Medicine Berlin, Campus Mitte, 10117 Berlin, Germany
  2. 2epo GmbH, 13125 Berlin, Germany
  1. ↵ Correspondence to: Gabriele Pecher, MD, Ph.D., Medical Clinic of Oncology and Hematology, Charité University Medicine Berlin, Campus Mitte, 10117 Berlin, Germany. Tel: +49 30450513131 Fax: +49 30450514906, e-mail: gabriele.pecher{at}charite.de
View Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Beta-(1-3),(1-6)-D-glucan Enhances the Effect of Low-dose Cyclophosphamide Treatment on A20 Lymphoma in Mice
ULF HARNACK, KLAUS ECKERT, GABRIELE PECHER
Anticancer Research Apr 2011, 31 (4) 1169-1172;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section